Form 4: Tenaya Therapeutics SVP Sells Shares for Tax Obligations
Insider Transaction Report (Form 4)
Tenaya Therapeutics' SVP of Finance, Tomohiro Higa, sold 1,367 shares of common stock at $1.33 per share to cover tax withholding obligations related to restricted stock unit vesting.
Summary
- Tomohiro Higa, Senior Vice President of Finance at Tenaya Therapeutics, Inc. (TNYA), reported a transaction on November 17, 2025.
- Higa sold 1,367 shares of Tenaya Therapeutics common stock at a price of $1.33 per share.
- The sale was conducted to cover tax withholding obligations associated with the vesting of restricted stock units (RSUs) that were awarded on August 15, 2024.
- Following this transaction, Higa beneficially owns 93,971 shares of Tenaya Therapeutics common stock.
- This total includes 50,470 shares that will be issued upon the future vesting of restricted stock units.
Sentiment
Score: 5
Explanation: The transaction is a routine sale of shares to cover tax withholding obligations upon the vesting of restricted stock units, which is a neutral event for the company's operational or financial performance.
Stakeholder Impact
- Minimal impact on shareholders as this is a routine, tax-related insider transaction and not indicative of a change in management's confidence or company fundamentals.
Key Dates
| Date | Description |
|---|---|
| August 15, 2024 | Award date of restricted stock units (RSUs) to the Reporting Person. |
| November 17, 2025 | Date of common stock sale by Tomohiro Higa to cover tax withholding obligations. |
Keywords
Tenaya Therapeutics, TNYA, Form 4, Insider Transaction, Stock Sale, Tax Withholding, Restricted Stock Units, Tomohiro Higa, SVP Finance
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.